Connacht Asset Management LP
- SEC CIK
- 0001802462
- Latest filing
- Nov 14, 2023
CRNX holding history
Crinetics Pharmaceuticals, Inc. in every 13F filed by Connacht Asset Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRNX overviewAll 13F holders of CRNXFull Q3 2023 holdings
- Shares (Q3 2023)
- 7,295
- Value
- $217.0K
- % of portfolio
- 1.3%
- Quarters held
- 6
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 7,295 | $217.0K | 1.3% | −5,111−41.2% | Reduced | Holders |
| Q2 2023 | 12,406 | $223.6K | 0.8% | −985−7.4% | Reduced | Holders |
| Q1 2023 | 13,391 | $215.1K | 0.6% | +1,054+8.5% | Added | Holders |
| Q4 2022 | 12,337 | $225.8K | 0.5% | −2,786−18.4% | Reduced | Holders |
| Q3 2022 | 15,123 | $297.0K | 0.6% | +3,842+34.1% | Added | Holders |
| Q2 2022 | 11,281 | $210.0K | 0.3% | +11,281 | New | Holders |